Targeting RNA N(6)-methyladenosine modification: a precise weapon in overcoming tumor immune escape

Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized the treatment of many types of cancer, particularly advanced-stage cancers. Nevertheless, although a subset of patients experiences dramatic and long-term disease regression in response to ICIs, most patients do not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Hao, Yi, Zhang, Xingda, Xu, Shouping, Pang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454167/
https://www.ncbi.nlm.nih.gov/pubmed/36071523
http://dx.doi.org/10.1186/s12943-022-01652-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454167/
https://www.ncbi.nlm.nih.gov/pubmed/36071523
http://dx.doi.org/10.1186/s12943-022-01652-3

Ejemplares similares